JPMorgan Chase & Co’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.61M | Buy |
|
|||||
|
2025
Q1 | $2.48M | Buy |
|
|||||
|
2024
Q4 | $1.62M | Buy |
|
|||||
|
2024
Q3 | $736K | Sell |
|
|||||
|
2024
Q2 | $584K | Buy |
|
|||||
|
2024
Q1 | $630K | Buy |
|
|||||
|
2023
Q4 | $303K | Buy |
|
|||||
|
2023
Q3 | $213K | Buy |
|
|||||
|
2023
Q2 | $331K | Buy |
|
|||||
|
2023
Q1 | $337K | Buy |
|
|||||
|
2022
Q4 | $130K | Sell |
|
|||||
|
2022
Q3 | $198K | Buy |
|
|||||
|
2022
Q2 | $178K | Sell |
|
|||||
|
2022
Q1 | $224K | Buy |
|
|||||
|
2021
Q4 | $257K | Buy |
|
|||||
|
2021
Q3 | $340K | Buy |
|
|||||
|
2021
Q2 | $471K | Sell |
|
|||||
|
2021
Q1 | $661K | Sell |
|
|||||
|
2020
Q4 | $1.7M | Sell |
|
|||||
|
2020
Q3 | $1.78M | Buy |
|
|||||
|
2020
Q2 | $144K | Buy |
|
|||||
|
2020
Q1 | $67K | Sell |
|
|||||
|
2019
Q4 | $54K | Hold |
|
|||||
|
2019
Q3 | $41K | Sell |
|
|||||
|
2019
Q2 | $1.29M | Buy |
|
|||||
|
2019
Q1 | $70K | Buy |
|
|||||
|
2018
Q4 | $34K | Sell |
|
|||||
|
2018
Q3 | $362K | Sell |
|
|||||
|
2018
Q2 | $509K | Buy |
|
|||||
|
2018
Q1 | $38K | Sell |
|
|||||
|
2017
Q4 | $119K | Sell |
|
|||||
|
2017
Q3 | $2.13M | Sell |
|
|||||
|
2017
Q2 | $3.14M | Sell |
|
|||||
|
2017
Q1 | $3.39M | Buy |
|